Characterizing the Frequency of Pharmacogenomic Biomarker-Guided Prescribing for Drugs with Pharmacogenomic Biomarker information in the FDA Labelling: A Pilot Study Using Data from an Electronic Health Record

Emily Beth Devine, Maher Khelifi, Katelyn Keyloun, Nathaniel Hendrix, Patrick Mathias, Christian Bock, Peter Tarczy-Hornoch. Characterizing the Frequency of Pharmacogenomic Biomarker-Guided Prescribing for Drugs with Pharmacogenomic Biomarker information in the FDA Labelling: A Pilot Study Using Data from an Electronic Health Record. In AMIA 2015, American Medical Informatics Association Annual Symposium, San Francisco, CA, USA, November 14-18, 2015. AMIA, 2015. [doi]

Abstract

Abstract is missing.